Items where Subject is "R Medicine > RS Pharmacy and materia medica"

Article

The Community Pharmacy Medicines Management Project Evaluation Team (2008) Evaluation of medication reviews conducted by community pharmacists: a quantitative analysis of documented issues and recommendations. British Journal of Clinical Pharmacology, 65 (3). pp. 386-396. ISSN 0306-5251

Community Pharmacy Medicines Management Team (2008) Patients’ experiences of a community pharmacy-led medicines management service. Health and Social Care in the Community, 16 (4). pp. 363-369. ISSN 0966-0410

Scientific Programme Committee of the 2015 PPRI Conference (2016) Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference. Journal of Pharmaceutical Policy and Practice, 9 (9). ISSN 2052-3211

Anderson, Michael ORCID: 0000-0002-8454-4640, Naci, Huseyin ORCID: 0000-0002-7192-5751, Morrison, Deborah, Osipenko, Leeza and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2018) A review of NICE appraisals of pharmaceuticals 2000-2016 found variation in establishing comparative clinical effectiveness. Journal of Clinical Epidemiology. ISSN 0895-4356

Angelis, Aris ORCID: 0000-0002-0261-4634 (2018) Evaluating the benefits of new drugs in health technology assessment using multiple criteria decision analysis: a case study on metastatic prostate cancer with the dental and pharmaceuticals benefits agency (TLV) in Sweden. Medical Decision Making: Policy and Practice, 3 (2). ISSN 2381-4683

Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: the Advance Value Framework. Social Science & Medicine, 188. pp. 137-156. ISSN 0277-9536

Angelis, Aris ORCID: 0000-0002-0261-4634 and Phillips, Lawrence D. (2021) Advancing structured decision-making in drug regulation at the FDA and EMA. British Journal of Clinical Pharmacology, 87 (2). 395 - 405. ISSN 0306-5251

Athanasakis, Kostas, Kyriopoulos, Ilias ORCID: 0000-0002-3932-8228 and Kyriopoulos, John (2018) To switch or not to switch? Patient attitudes towards generic substitution in Greece. Journal of Pharmaceutical Health Services Research, 9 (3). pp. 271-273. ISSN 1759-8885

Bakker, Gerben ORCID: 0000-0001-6109-0693 (2010) Book review: Wellcome & co.: knowledge, trust, profit and the transformation of the British pharmaceutical industry, 1880-1940. Medical History, 54 (2). pp. 260-261. ISSN 0025-7273

Banerjee, Sube, Hellier, J, Romer, R, Dewey, M, Knapp, Martin ORCID: 0000-0003-1427-0215, Ballard, C, Baldwin, Robert, Bentham, Peter, Fox, C., Holmes, Clive, Katona, Cornelius, Livingston, G., Lawton, C, McCrae, N, Moniz-Cook, E, Murray, J, Nurock, J, Orrell, Martin, O'Brien, J, Poppe, M, Thomas, A, Walwyn, R, Wilson, K, Burns, A and Lindesay, James (2013) Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technology Assessment, 17 (7). ISSN 1366-5278

Bergsma, W. P. ORCID: 0000-0002-2422-2359, Aris, E. M. D. and Tibaldi, F. S. (2013) Linear Categorical Marginal Modeling of solicited symptoms in vaccine clinical trials. Statistics in Biopharmaceutical Research, 5 (1). pp. 27-37. ISSN 1946-6315

Bogacka, Barbara, Patan, Maciej, Johnson, Patrick, J, Youdim, K and Atkinson, Anthony C. (2011) Optimum design of experiments for enzyme inhibition kinetic models. Journal of Biopharmaceutical Statistics, 21 (3). pp. 555-572. ISSN 1054-3406

Bradley, James and Vandoros, Sotiris (2012) Creative compliance in pharmaceutical markets: the case of profit controls. Expert Review of Pharmacoeconomics and Outcomes Research, 12 (1). pp. 31-38. ISSN 1473-7167

Cerri, Karin H., Knapp, Martin ORCID: 0000-0003-1427-0215 and Fernandez, Jose-Luis ORCID: 0000-0002-4190-7341 (2013) Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making. European Journal of Health Economics, 15 (7). pp. 681-695. ISSN 1618-7598

Cornford, Tony ORCID: 0000-0001-9202-1498, Savage, Imogen, Jani, Yogini, Franklin, Bryony Dean, Barber, Nick, Slee, Ann and Jacklin, Ann (2010) Learning lessons from electronic prescribing implementations in secondary care. Studies in Health Technology and Informatics, 160. pp. 233-237. ISSN 0926-9630

Costa-Font, Joan ORCID: 0000-0001-7174-7919 (2016) Deregulation and access to medicines: the Peruvian experience. Journal of International Development, 28 (6). pp. 997-1005. ISSN 0954-1748

Costa-Font, Joan ORCID: 0000-0001-7174-7919, McGuire, Alistair ORCID: 0000-0002-5367-9841 and Varol, Nebibe (2015) Regulation effects on the adoption of new medicines. Empirical Economics, 49 (3). pp. 1101-1121. ISSN 0377-7332

Crea, Giovanni, Galizzi, Matteo M. ORCID: 0000-0002-7757-5625, Linnosmaa, Ismo and Miraldo, Marisa (2019) Physician altruism and moral hazard: (no) evidence from Finnish national prescriptions data. Journal of Health Economics, 65. pp. 153-169. ISSN 0167-6296

Ferrario, Alessandra and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden. Social Science & Medicine, 124. pp. 39-47. ISSN 0277-9536

Ferrario, Alessandra, Sautenkova, Nina, Bezverhni, Zinaida, Seicas, Rita, Habicht, Jarno, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Safta, Vladimir (2014) An in-depth analysis of pharmaceutical regulation in the Republic of Moldova. Journal of Pharmaceutical Policy and Practice, 7 (1). p. 4. ISSN 2052-3211

Gandecha, Reshma, Klecun, Ela ORCID: 0000-0002-0329-1566, Jacklin, Ann and Williams, Simon (2005) What the national IT programme means for pharmacy and pharmacists. Pharmaceutical Journal, 275 (7357). pp. 56-60. ISSN 0031-6873

Gerard, Karen, Tinelli, Michela ORCID: 0000-0002-8816-4389, Latter, Sue, Blenkinsopp, Alison and Smith, Alesha (2012) Valuing the extended role of prescribing pharmacist in general practice: results from a discrete choice experiment. Value in Health, 15 (5). pp. 699-707. ISSN 1098-3015

Heims, Eva and Moxon, Sophie (2024) Mechanisms of regulatory capture: testing claims of industry influence in the case of Vioxx. Regulation and Governance, 18 (1). pp. 139-157. ISSN 1748-5983

Hernandez, Inmaculada, Cousin, Emma, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Gabriel, Nico, Cameron, Teresa and Sullivan, Sean D. (2024) Medicare drug price negotiation: the complexities of selecting therapeutic alternatives for estimating comparative effectiveness. Journal of Managed Care & Specialty Pharmacy, 30 (3). 218 - 225. ISSN 2376-1032

Hoefer, Carl and Krauss, Alexander ORCID: 0000-0002-1783-2765 (2021) Measures of effectiveness in medical research: reporting both absolute and relative measures. Studies in history and philosophy of science, 88. 280 - 283. ISSN 0039-3681

Hong, Jihyung, Reed, Catherine, Novick, Diego, Haro, Josep Maria and Aguado, Jaume (2011) Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Study. Psychiatry Research, 190 (1). pp. 110-114. ISSN 0165-1781

Howard, Robert, McShane, Rupert, Lindesay, James, Ritchie, Craig, Baldwin, Ashley, Barber, Robert, Burns, Alistair, Dening, Tom, Findlay, David, Holmes, Clive, Jones, Robert, Jones, Roy, McKeith, Ian, Macharouthu, Ajay, O'Brien, John, Sheehan, Bart, Juszczak, Edmund, Katona, Cornelius, Hills, Robert, Knapp, Martin ORCID: 0000-0003-1427-0215, Ballard, Clive, Brown, Richard G, Banerjee, Sube, Adams, Jessica, Johnson, Tony, Bentham, Peter and Phillips, Patrick P J (2015) Nursing home placement in the Donepezil and Memantine in moderate to severe Alzheimer's disease (DOMINO-AD) trial: secondary and post-hoc analyses. The Lancet Neurology, 14 (12). pp. 1171-1181. ISSN 1474-4422

Ikeda, S., Ikegami, N., Oliver, Adam and Ikeda, M. (1996) A case for the adoption of pharmacoeconomic guidelines in Japan. PharmacoEconomics, 10. pp. 546-551. ISSN 1170-7690

Jackson, Emily ORCID: 0000-0002-2052-2776, Feldschreiber, P and Breckenridge, A (2017) Regulatory consequences of “Brexit” for the development of medicinal products. Clinical Pharmacology and Therapeutics, 102. pp. 183-184. ISSN 0009-9236

Jackson, N., Atar, D., Borentain, M., Breithardt, G., van Eickels, M., Endres, M., Fraass, U., Friede, T., Hannachi, H., Janmohamed, S., Kreuzer, J., Landray, M., Lautsch, D., Le Floch, C., Mol, P., Naci, H. ORCID: 0000-0002-7192-5751, Samani, N. J., Svensson, A., Thorstensen, C., Tijssen, J., Vandzhura, V., Zalewski, A. and Kirchhof, P. (2015) Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology. European Heart Journal. ISSN 0195-668X

Jaffray, Mariesha, Bond, Christine M., Watson, M. C., Hannaford, Philip, Tinelli, Michela ORCID: 0000-0002-8816-4389, Scott, A., Lee, A., Blenkinsopp, Alison, Anderson, Cameron, Avery, Anthony, Bissell, P. and Krksa, J. (2007) The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Family Practice, 24 (2). pp. 189-200. ISSN 0263-2136

Jiménez Rubio, Dolores and Hernández-Quevedo, Cristina (2010) Spain: the effect of country of birth on patterns of pharmaceutical use. Eurohealth, 16 (4). pp. 18-19. ISSN 1356-1030

Kamphuis, Bregtje W. and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2021) Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration. Health Policy OPEN, 2. ISSN 2590-2296

Kanavos, Panos ORCID: 0000-0001-9518-3089 (1999) Financing pharmaceuticals in transition. Croatian Medical Journal, 40 (June). pp. 244-259. ISSN 0353-9504

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Angelis, Aris ORCID: 0000-0002-0261-4634 (2014) Acquiring pharmaceutical industry assets in the UK: 1 + 1 = 1? Pharmaceutical Medicine, online. ISSN 1178-2595

Kanavos, Panos ORCID: 0000-0001-9518-3089, Angelis, Aris ORCID: 0000-0002-0261-4634 and Drummond, Michael (2019) An EU-wide approach to HTA: an irrelevant development or an opportunity not to be missed? European Journal of Health Economics, 20 (3). pp. 329-332. ISSN 1618-7598

Kanavos, Panos ORCID: 0000-0001-9518-3089, Kamphuis, Bregtje, Fontrier, Anna-Maria, Parkin, Georgia Colville, Saleh, Shadi and Akhras, Kasey S. (2020) Pricing of in-patent pharmaceuticals in the Middle East and North Africa: is external reference pricing implemented optimally? Health Policy, 124 (12). 1297 - 1309. ISSN 0168-8510

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (1999) Outstanding regulatory issues in the European Union pharmaceutical market. PharmacoEconomics, 15 (6). pp. 519-533. ISSN 1170-7690

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Nicod, Elena (2012) What is wrong with orphan drug policies?: suggestions for ways forward. Value in Health, 15 (8). pp. 1182-1184. ISSN 1098-3015

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Vandoros, Sotiris (2011) Determinants of branded prescription medicine prices in OECD countries. Health Economics, Policy and Law, 6 (3). pp. 1-31. ISSN 1744-1331

Kawalec, Paweł, Sagan, Anna and Pilc, Andrzej (2016) The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe. Orphanet Journal of Rare Diseases, 11 (122). ISSN 1750-1172

Kravdal, Øystein, Grundy, Emily ORCID: 0000-0002-9633-1116 and Skirbekk, Vegard (2017) Fertility history and use of antidepressant medication in late mid-life: a register-based analysis of Norwegian women and men. Aging and Mental Health, 21 (5). pp. 477-486. ISSN 1360-7863

Lagarde, Mylène ORCID: 0000-0002-5713-2659 and Blaauw, Duane (2023) Levels and determinants of over-prescribing of antibiotics in the public and private primary care sectors in South Africa. BMJ Global Health, 8 (7). ISSN 2059-7908

Latonen, S., Neuvonen, E., Juppo, A. M., Seeck, H. ORCID: 0000-0001-6209-651X and Airaksinen, M. (2024) Crisis management in community pharmacies during a pandemic. Research in Social and Administrative Pharmacy, 20 (9). 940 - 948. ISSN 1551-7411

Levitan, Bennett, Phillips, Lawrence D. and Walker, Stuart (2014) Structured approaches to benefit-risk assessment: a case study and the patient perspective. Therapeutic Innovation and Regulatory Science, 48 (5). pp. 564-573. ISSN 2168-4790

Lewer, D., O'Reilly, C., Mojtabai, R. and Evans-Lacko, S. ORCID: 0000-0003-4691-2630 (2015) Antidepressant use in 27 European countries: associations with sociodemographic, cultural and economic factors. British Journal of Psychiatry, 207 (3). pp. 221-226. ISSN 0007-1250

Liebenau, Jonathan ORCID: 0000-0001-6536-6319 (2013) Modernising the business of health: pharmaceuticals in Britain, in comparison with Germany and the United States, 1890-1940. Industrial and Corporate Change, 22 (3). pp. 807-847. ISSN 0960-6491

Luciano, Juan V., D’Amico, Francesco, Cerdà-Lafont, Marta, Peñarrubia-María, María T., Knapp, Martin ORCID: 0000-0003-1427-0215, Cuesta-Vargas, Antonio I., Serrano-Blanco, Antoni and García-Campayo, Javier (2014) Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial. Arthritis Research and Therapy, 16 (5). p. 451. ISSN 1478-6354

Luyten, Jeroen and Beutels, Philippe (2009) Costing infectious disease outbreaks for economic evaluation. PharmacoEconomics, 27 (5). pp. 379-389. ISSN 1170-7690

Luyten, Jeroen, Desmet, Pieter, Dorgali, Veronica, Hens, Niel and Beutels, Philippe (2014) Kicking against the pricks: vaccine sceptics have a different social orientation. European Journal of Public Health, 24 (2). pp. 310-314. ISSN 1101-1262

Luyten, Jeroen, Dorgali, Veronica, Hens, Niel and Beutels, Philippe (2013) Public preferences over efficiency, equity and autonomy in vaccination policy: an empirical study. Social Science & Medicine, 77. pp. 84-89. ISSN 0277-9536

Luyten, Jeroen, Marais, Christiaan, Hens, Niel, De Schrijver, Koen and Beutels, Philippe (2011) Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis A patients. Value in Health, 14 (2). pp. 282-290. ISSN 1098-3015

Luyten, Jeroen, Van de Sande, Stefaan, De Schrijver, Koen, Van Damme, Pierre and Beutels, Philippe (2012) Cost-effectiveness of hepatitis A vaccination for adults in Belgium. Vaccine, 30 (42). pp. 6070-6080. ISSN 0264-410X

Luyten, Jeroen, Vandevelde, Antoon, Van Damme, Pierre and Beutels, Philippe (2011) Vaccination policy and ethical challenges posed by herd immunity, suboptimal uptake and subgroup targeting. Public Health Ethics, 4 (3). pp. 280-291. ISSN 1754-9973

Manfrin, Andrea, Knapp, Martin ORCID: 0000-0003-1427-0215, Cicchetti, Americo, Mandelli, Andrea and Tinelli, Michela ORCID: 0000-0002-8816-4389 (2018) VP164 Applying health technology assessment to pharmacy: the Italian-Medicine-Use-Review-Health Technology Assessment. International Journal of Technology Assessment in Health Care, 33 (S1). ISSN 0266-4623

Maynou-Pujolras, Laia ORCID: 0000-0002-0447-2959 and Cairns, John (2015) Why do some countries approve a cancer drug and others don't? Journal of Cancer Policy, 4. pp. 21-25. ISSN 2213-5383

Mehta, Reena, Onatade, Raliat, Vlachos, Savvas, Sloss, Rhona and Maharaj, Ritesh ORCID: 0000-0003-3667-2426 (2023) The association of a critical care electronic prescribing system with the quality of patient care provided by clinical pharmacists - a prospective, observational cohort study. International Journal of Medical Informatics, 177. ISSN 1386-5056

Mercadante, Eduardo ORCID: 0000-0001-5597-4863 and Paranhos, Julia (2022) Pharmaceutical patent term extension and patent prosecution in Brazil (1997-2018). Cadernos de saude publica, 38 (1). ISSN 0102-311X

Michaeli, Daniel Tobias, Mills, Mackenzie, Michaeli, Thomas, Miracolo, Aurelio and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2022) Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA. Investigational New Drugs, 40 (4). 798 - 809. ISSN 0167-6997

Mossialos, Elias ORCID: 0000-0001-8664-9297, Courtin, Emilie ORCID: 0009-0006-4656-2967, Naci, Huseyin ORCID: 0000-0002-7192-5751, Benrimoj, Shalom, Bouvy, Marcel, Farris, Karen, Noyce, Peter and Sketris, Ingrid (2015) From "retailers" to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy, 119 (5). pp. 628-639. ISSN 0168-8510

Mt-Isa, Shahrul, Hallgreen, Christine E., Wang, Nan, Callréus, Torbjörn, Genov, Georgy, Hirsch, Ian, Hobbiger, Stephen F., Hockley, Kimberley S., Luciani, Davide, Phillips, Lawrence D., Quartey, George, Sarac, Sinan B., Stoeckert, Isabelle, Tzoulaki, Ioanna, Micaleff, Alain and Ashby, Deborah (2014) Balancing benefit and risk of medicines: a systematic review and classification of available methodologies. Pharmacoepidemiology and Drug Safety, 23 (7). pp. 667-678. ISSN 1053-8569

Mwita, Stanley, Jande, Mary, Marwa, Karol, Hamasaki, Kayo, Katabalo, Deogratius, Burger, Johanita, Godman, Brian, Ferrario, Alessandra, Massele, Amos and Ruganuza, Deodatus (2017) Medicines dispensers' knowledge on the implementation of an artemisinin-based combination therapy policy for the treatment of uncomplicated malaria in Tanzania. Journal of Pharmaceutical Health Services Research. ISSN 1759-8885

Naci, Huseyin ORCID: 0000-0002-7192-5751, Carter, Alexander W. and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2015) Double failure: the shared accountability of governments and firms for the innovation deficit in the pharmaceutical sector. BMJ. ISSN 1756-1833

Naci, Huseyin ORCID: 0000-0002-7192-5751, Carter, Alexander W. and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2015) Why the drug development pipeline is not delivering better medicines. BMJ, 351. ISSN 1756-1833

Naci, Huseyin ORCID: 0000-0002-7192-5751 and Kesselheim, Aaron S. (2020) Specialty drugs: a distinctly American phenomenon. New England Journal of Medicine, 382 (23). 2179 - 2181. ISSN 0028-4793

Naci, Huseyin ORCID: 0000-0002-7192-5751, Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Kesselheim, Aaron S., Dr.rer.nat, Beate Wiesler, Rochaix, Lise, Redberg, Rita, Salanti, Georgia, Jackson, Emily, Garner, Sarah, Stroup, Scott and Cipriani, Andrea (2020) Generating comparative evidence on new drugs and devices before approval. The Lancet, 395 (10228). 986 - 997. ISSN 0140-6736

Naci, Huseyin ORCID: 0000-0002-7192-5751, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Gupta, Radhika and Ioannidis, John P. A. (2017) Timing and characteristics of cumulative evidence available on novel therapeutic agents receiving Food and Drug Administration accelerated approval. The Milbank Quarterly, 95 (2). 261 - 290. ISSN 0887-378X

Nicod, Elena, Annemans, Lieven, Bucsics, Anna, Lee, Anne, Upadhyaya, Sheela and Facey, Karen (2017) HTA programme response to the challenges of dealing with orphan medicinal products: process evaluation in selected European countries. Health Policy. ISSN 0168-8510

Oliver, Adam, Ikegami, N. and Ikeda, S. (1999) The Japanese government's pharmaceutical policy and its effect on hospital financial viability. Journal of Health Services Research and Policy, 4. pp. 27-32. ISSN 1355-8196

Pan, Yi-Ju, Knapp, Martin ORCID: 0000-0003-1427-0215 and McCrone, Paul R. (2012) Cost-effectiveness comparisons between antidepressant treatments in depression: evidence from database analyses and prospective studies. Journal of Affective Disorders, 139 (2). pp. 113-125. ISSN 0165-0327

Phillips, Lawrence D., Fasolo, Barbara ORCID: 0000-0002-4643-5689, Zafiropoulos, Nikolaos and Beyer, Andrea (2011) Is quantitative benefit–risk modelling of drugs desirable or possible? Drug Discovery Today: Technologies, 8 (1). e3-e10. ISSN 1740-6749

Renwick, Mathew and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2018) What are the economic barriers of antibiotic R&D and how can we overcome them? Expert Opinion on Drug Discovery, 13 (10). pp. 889-892. ISSN 1746-0441

Salas-Vega, Sebastian, Bertling, Annika and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2016) A comparative study of drug listing recommendations and the decision-making process in Australia, the Netherlands, Sweden, and the UK. Health Policy, 120 (10). pp. 1104-1114. ISSN 0168-8510

Salas-Vega, Sebastian, Shearer, Emily and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2020) Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US. Social Science & Medicine, 258. ISSN 0277-9536

Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Davis, Courtney (2020) Approval of cancer drugs with uncertain therapeutic value: a comparison of regulatory decisions in Europe and the United States. Milbank Quarterly, 98 (4). 1219 - 1256. ISSN 0887-378X

Sampat, Bhaven N. and Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2015) Drug patenting in India: looking back andlooking forward. Nature Reviews: Drug Discovery, 14. pp. 519-520. ISSN 1474-1776

Sampat, Bhaven N., Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 and Amin, Tahir M. (2012) Challenges to India's pharmaceutical patent laws. Science, 337 (6093). pp. 414-415. ISSN 0036-8075

Schlag, Anne Katrin, Baldwin, David S., Barnes, Michael, Bazire, Steve, Coathup, Rachel, Curran, H. Valerie, McShane, Rupert, Phillips, Lawrence D., Singh, Ilina and Nutt, David J. (2020) Medical cannabis in the UK: from principle to practice. Journal of Psychopharmacology, 34 (9). 931 - 937. ISSN 0269-8811

Serra-Sastre, Victoria and McGuire, Alistair ORCID: 0000-0002-5367-9841 (2013) Information and diffusion of new prescription drugs. Applied Economics, 45 (15). pp. 2049-2057. ISSN 0003-6846

Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2011) The political contradictions of incremental innovation: lessons from pharmaceutical patent examination in Brazil. Politics & Society, 39 (2). pp. 143-174. ISSN 0032-3292

Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 and Sampat, Bhaven N. (2018) Indian pharmaceutical patent prosecution: the changing role of Section 3(d). PLOS ONE, 13 (4). ISSN 1932-6203

Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835, Sampat, Bhaven N. and Kapczynski, Amy (2020) Patents, trade, and medicines: past, present, and future. Review of International Political Economy, 27 (1). 75 - 97. ISSN 0969-2290

Shahzad, Mahnum, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Wagner, Anita K. (2023) Association between preapproval confirmatory trial initiation and conversion to traditional approval or withdrawal in the FDA accelerated approval pathway. JAMA, 329 (9). 760 - 761. ISSN 0098-7484

Simpkin, Victoria, Namubiru-Mwaura, Evelyn, Clarke, Lorcan and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2019) Investing in health R&D: where we are, what limits us, and how to make progress in Africa. BMJ Global Health, 4 (2). ISSN 2059-7908

Sosa, M. Lourdes ORCID: 0000-0003-0303-2238 (2009) Application-specific R&D capabilities and the advantage of incumbents: evidence from the anticancer drug market. Management Science, 55 (8). pp. 1409-1422. ISSN 0025-1909

Sosa, M. Lourdes ORCID: 0000-0003-0303-2238 (2013) Decoupling market incumbency from organizational prehistory: locating the real sources of competitive advantage in R&D for radical innovation. Strategic Management Journal, 34 (2). pp. 245-255. ISSN 0143-2095

Srivastava, Divya ORCID: 0000-0001-5135-3592 and McGuire, Alistair ORCID: 0000-0002-5367-9841 (2014) Analysis of prices paid by low-income countries: how price sensitive is government demand for medicines? BMC Public Health, 14 (1). p. 767. ISSN 1471-2458

Stoneman, Paul, Sturgis, Patrick ORCID: 0000-0003-1180-3493 and Allum, Nick (2013) Understanding support for complementary and alternative medicine in general populations: Use and perceived efficacy. Health (United Kingdom), 17 (5). pp. 512-529. ISSN 1363-4593

Sullivan, Sean D., Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Cousin, Emma M., Kirihennedige, Ayuri S. and Hernandez, Inmaculada (2024) Integrating price benchmarks and comparative clinical effectiveness to inform the medicare drug price negotiation program. Value in Health, 27 (10). 1348 - 1357. ISSN 1098-3015

Thambisetty, Sivaramjani (2019) Improving access to patented medicines: are human rights getting in the way? Intellectual Property Quarterly, 4. pp. 284-305. ISSN 1364-906X

Thambisetty, Sivaramjani (2014) Novartis v Union of India and the person skilled in the art: a missed opportunity. Queen Mary Journal of Intellectual Property, 4 (1). pp. 79-94. ISSN 2045-9807

Tinelli, Michela ORCID: 0000-0002-8816-4389 (2017) Better outcomes for the patient, the provider and the society now: this is not a dream, and the pharmacist could help! BMJ. ISSN 1756-1833

Tinelli, Michela ORCID: 0000-0002-8816-4389 (2002) Costi dell’aterosclerosi. Farmacoeconomia News, 2. pp. 27-51. ISSN 1126-4705

Tinelli, Michela ORCID: 0000-0002-8816-4389 (2002) Neuropatie diabetiche ed L-carnitina: nuove prospettive di trattamento. Farmacoeconomia News, 3. ISSN 1126-4705

Tinelli, Michela ORCID: 0000-0002-8816-4389, Blenkinsopp, Alison, Latter, Sue, Smith, Alesha and Chapman, Stephen R. (2015) Survey of patients' experiences and perceptions of care provided by nurse and pharmacist independent prescribers in primary care. Health Expectations, 18 (5). pp. 1241-1255. ISSN 1369-6513

Tinelli, Michela ORCID: 0000-0002-8816-4389, Jaffray, M, Krksa, J. and Bond, Christine M. (2007) The MEDMAN project: evaluation of the medicines management training for community pharmacists. Pharmacy Education, 7 (3). pp. 207-214. ISSN 1560-2214

Tinelli, Michela ORCID: 0000-0002-8816-4389, Ryan, M. and Bond, Christine (2007) Economic evaluation advancement in pharmacy: discrete choice experiments (DCEs). International Journal of Pharmacy Practice, 15 (s1). ISSN 0961-7671

Tinelli, Michela ORCID: 0000-0002-8816-4389, Ryan, M. and Bond, Christine (2010) Session 1A: methods. Discrete choice experiments (DCEs) to inform pharmacy policy: going beyond Quality Adjusted Life Years (QALYs). International Journal of Pharmacy Practice, 18 (S). pp. 1-4. ISSN 0961-7671

Tinelli, Michela ORCID: 0000-0002-8816-4389, Ryan, Mandy and Bond, Christine (2006) Patient-centred approach to policy development: a pharmacy-led medicines management service. International Journal of Pharmacy Practice, 14 (S). pp. 71-72. ISSN 0961-7671

Tinelli, Michela ORCID: 0000-0002-8816-4389, White, John and Manfrin, Andrea (2018) Novel pharmacist-led intervention secures the minimally important difference (MID) in Asthma Control Test (ACT) score: better outcomes for patients and the healthcare provider. BMJ Open Respiratory Research, 5 (1). e000322. ISSN 2052-4439

Vandoros, Sotiris and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2014) Parallel trade and pharmaceutical prices: a game-theoretic approach and empirical evidence from the European Union. World Economy, 37 (6). pp. 856-880. ISSN 0378-5920

Vogler, Sabine, Zimmermann, Nina, Ferrario, Alessandra, Wirtz, Veronika J and Babar, Zaheer-Ud-Din (2015) Challenges and opportunities for pharmaceutical pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice, 8 (Suppl). ISSN 2052-3211

Von der Schulenburg, Fritz, Vandoros, Sotiris and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2011) The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors. Health Economics Review, 1 (1). pp. 1-8. ISSN 2191-1991

Vreman, Rick A., Naci, Huseyin ORCID: 0000-0002-7192-5751, Goettsch, Wim G., Mantel-Teeuwisse, Aukje K., Schneeweiss, Sebastian G., Leufkens, Hubert G.M. and Kesselheim, Aaron S. (2020) Decision making under uncertainty: comparing regulatory and health technology assessment reviews of medicines in the United States and Europe. Clinical Pharmacology and Therapeutics, 108 (2). pp. 350-357. ISSN 0009-9236

Wallis, Patrick ORCID: 0000-0003-1434-515X (2000) The first English histories of pharmacy - their origins and influences. Pharmacy in History, 42 (1). pp. 36-46. ISSN 0031-7047

Wei, Yuxuan, Zhang, Yichen, Xu, Ziyue, Wang, Guoan, Zhou, Yue, Li, Huangqianyu, Shi, Luwen, Naci, Huseyin ORCID: 0000-0002-7192-5751, Wagner, Anita K. and Guan, Xiaodong (2024) Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001–2020. The Lancet Regional Health - Western Pacific, 45. ISSN 2666-6065

Wilson, Leslie, Turkistani, Fatema A., Huang, Wei, Tran, Dang M. and Kuo Lin, Tracy (2018) The impact of alternative pricing methods for drugs in California Workers’ Compensation System: fee-schedule pricing. PLOS ONE, 13 (5). e0197449. ISSN 1932-6203

Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform. Bulletin of the World Health Organization, 93 (9). pp. 606-613. ISSN 0042-9686

Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) A comparison of generic drug prices in seven European countries: a methodological analysis. BMC Health Services Research, 17 (242). pp. 1-7. ISSN 1472-6963

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Kesselheim, Aaron S., Kuha, Jouni ORCID: 0000-0002-1156-8465 and Luyten, Jeroen (2024) Sales revenues for new therapeutic agents approved by the United States Food and Drug Administration from 1995 to 2014: a retrospective study. Value in Health, 27 (10). 1373 - 1381. ISSN 1098-3015

Zafiropoulos, Nikolaos, Phillips, Lawrence D., Pignatti, Francesco and Luria, Xavier (2012) Evaluating benefit-risk: an Agency perspective. Regulatory Rapporteur, 9 (6). pp. 5-8. ISSN 1742-8955

da Silva Menolli, Poliana Vieira, Brummel, Adriana Mitsue Ivama, Guidoni, Camilo Molino and Girotto, Edmarlon (2024) Patient’s perception of medication and nonadherence to chronic disease treatments. A population-based study in Brazil. Journal of Pharmaceutical Health Services Research, 15 (1). ISSN 1759-8885

van Amsterdam, Jan, Phillips, Lawrence D., Henderson, Graeme, Bell, James, Bowden-Jones, Owen, Hammersley, Richard, Ramsey, John, Taylor, Polly, Dale-Perera, Annette, Melichar, Jan, van den Brink, Wim and Nutt, David (2015) Ranking the harm of non-medically used prescription opioids in the UK. Regulatory Toxicology and Pharmacology, 73 (3). pp. 999-1004. ISSN 0273-2300

Book Section

Collins, John (2017) Regulation as global drug governance: how new is the NPS phenomenon? In: Corazza, Ornella and Roman-Urrestarazu, Andres, (eds.) Novel Psychoactive Substances. Springer Berlin / Heidelberg, Cham, Switzerland, pp. 23-41. ISBN 9783319605999

Permanand, Govin and Altenstetter, Christa (2004) The politics of the EU pharmaceutical industry. In: Mossialos, Elias, Mrazek, Monique and Walley, Tom, (eds.) Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality. Open University, Maidenhead, pp. 38-54. ISBN 0335214657

Phillips, Lawrence D. (2013) Benefit-risk modeling of medicinal products: methods and applications. In: Sashegyi, Andreas, Felli, James and Noel, Rebecca, (eds.) Benefit-Risk Assessment in Pharmaceutical Research and Development. CRC Press, Boca Raton, pp. 59-96. ISBN 9781439867945

Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2011) The politics of patents and drugs in Brazil and Mexico: the industrial bases of health policies. In: Shadlen, Kenneth C., Guennif, Samira, Guzmán, Alenka and Lalitha, N., (eds.) Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries. Edward Elgar, pp. 178-201. ISBN 9781849800143

Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835, Guennif, Samira, Guzmán, Alenka and Lalitha, N. (2011) Globalization, intellectual property rights, and pharmaceuticals: meeting the challenges to addressing health gaps in the new international environment. In: Shadlen, Kenneth C., Guennif, Samira, Guzmán, Alenka and Lalitha, N., (eds.) Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries. Edward Elgar, pp. 1-28. ISBN 9781849800143

Monograph

European Medicines Agency (2014) Benefit-risk methodology project:update on work package 5: effects table pilot (phase I). . European Medicines Agency, London.

European Medicines Agency (2011) Benefit-risk methodology project:work package 1 report: description of the current practice of benefit-risk assessment for centralised procedure products in the EU regulatory network. . European Medicines Agency, London.

European Medicines Agency (2011) Benefit-risk methodology project:work package 2 report: applicability of current tools and processes for regulatory benefit-risk assessment. . European Medicines Agency, London.

European Medicines Agency (2011) Benefit-risk methodology project:work package 3 report: field tests. . European Medicines Agency, London.

European Medicines Agency (2012) Benefit-risk methodology project:work package 4 report: benefit-risk tools and processes. . European Medicines Agency, London.

Medical Technology Research Group – LSE Health London School of Economics and Political Science (2011) Differences in costs of and access to pharmaceutical products in the EU. . European Parliament, Brussels. (Submitted)

Alkazemi, Mariam (2018) Regulation of healthcare advertisements: comparing media regulation of the pharmaceutical industry in Kuwait and the GCC. LSE Middle East Centre papers series (23). LSE Middle East Centre, London, UK.

Beutels, Philippe, Luyten, Jeroen, Lejeune, Olivier, Hens, Niel, Bilcke, Joke, De Schrijver, Koen, Van de Sande, Stefaan, Van Herck, Koen and Van Damme, Pierre (2008) Evaluatie van universele en doelgroep hepatitis A vaccinatie opties in België = Evaluation of universal and targeted hepatitis A vaccination programs in Belgium. KCE reports 98A ((D/2008/10.273/88)). Federaal Kenniscentrum voor de Gezondheidszorg (KCE), Brussels, Belgium.

Bonser, Andrew, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Taylor, David (2016) Tender Loving Care? Purchasing medicines for continuing therapeutic improvement and better health outcomes. . London School of Economics and Political Science, London, UK.

Cockburn, Iain, Lanjouw, Jean O. and Schankerman, Mark ORCID: 0009-0006-1071-7672 (2014) Patents and the global diffusion of new drugs. CEP Discussion Papers (CEPDP1298). London School of Economics and Political Science. Centre for Economic Performance, London, UK.

Costa-i-Font, Joan ORCID: 0000-0001-7174-7919, Hernandez-Quevedo, Christina and Sato, Azusa (2013) A 'Health Kuznets' curve'? Cross-country and longitudinal evidence. CESifo working paper (4446). CESifo Group, Munich, Germany.

Costa-i-Font, Joan ORCID: 0000-0001-7174-7919, Varol, Nebibe and McGuire, Alistair ORCID: 0000-0002-5367-9841 (2011) Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008. CESifo working paper (3441). CESifo Group, Munich, Germany.

Feick, Jürgen (2005) Learning and interest accommodation in policy and institutional change: EC risk regulation in the pharmaceuticals sector. CARR Discussion Papers (DP 25). ESRC Centre for Analysis of Risk and Regulation, London, UK. ISBN 0753017466

Ferrario, Alessandra and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Managed entry agreements for pharmaceuticals: the European experience. . EMiNet, Brussels, Belgium.

Hibberd, Ralph, Barber, Nick, Cornford, Tony ORCID: 0000-0001-9202-1498 and Lichtner, Valentina (2012) The evaluation of the electronic prescription service in primary care: interim report on the findings from the evaluation in early implementer sites. . University College London, London, UK.

Hughes, Diana, Waddingham, Ed, A., J., Mt-Isa, Shahrul, Goginsky, Alesia, Chan, Edmond, Downey, Gerald, Hallgreen, Christine E., Hockley, Kimberley S., Juhaeri, Juhaeri, Lieftucht, Alfons, Metcalfe, Marilyn, A., Noel, Rebecca, A., Phillips, Lawrence D., Ashby, Deborah and Micaleff, Alain (2014) IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines. . PROTECT Consortium, London.

Jaffray, Mariesha, Bond, Christine and Tinelli, Michela ORCID: 0000-0002-8816-4389 (2005) The Community Pharmacy Medicines Management Project: final report. . University of Aderdeen, Keele University, University of Nottingham, The College of Pharmacy Practice, UK.

Kalbfuß, Jörg, Odermatt, Reto and Stutzer, Alois (2018) Medical marijuana laws and mental health in the United States. CEP Discussion Papers (CEPDP1546). London School of Economics and Political Science. Centre for Economic Performance, London, UK.

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2001) Overview of pharmaceutical pricing and reimbursement regulation. . LSE Health, London, U.K..

Kanavos, Panos ORCID: 0000-0001-9518-3089, Vandoros, Sotiris, Irwin, Rachel, Nicod, Elena and Casson, Margaret (2010) The European pharmaceutical market and policies - outlook for the future. . European Parliament, Brussels, Belgium.

Micaleff, Alain, Callreus, Tornbjorn, Phillips, Lawrence D., Hughes, Diana, Hockley, Kimberley, Wang, Nan and Luciani, David (2013) IMI work package 5: report 1:b:iii benefit - riskwave 1 case study report:Raptiva® (efalizumab). . PROTECT Consortium, London.

Mossialos, Elias ORCID: 0000-0001-8664-9297, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Abel-Smith, B. (1994) Policy options for pharmaceutical research and development in the European Community. Science and Technology Options Assessment Programme. European Parliament, Brussels, Belgium.

Mossialos, Elias ORCID: 0000-0001-8664-9297 and Mrazek, Monique F. (2003) The regulation of pharmacies in six countries: report prepared for the Office of Fair Trading. . Office of Fair Trading, London, UK.

Mossialos, Elias ORCID: 0000-0001-8664-9297 and Srivastava, Divya ORCID: 0000-0001-5135-3592 (2008) Pharmaceutical policies in Finland - challenges and opportunities. Observatory Studies Series (10). World Health Organization, Copenhagen, Denmark.

Mt-Isa, Shahrul, Hallgreen, Christine, E., Asiimwe, Alex, Downey, Gerry, Genov, Georgy, Hermann, Richard, Hughes, Diana, Lieftucht, Alfons, Noel, Rebecca, Peters, Ruth, Phillips, Lawrence D., Shepherd, Susan, Micaleff, Alain, Ashby, Deborah and Tzoulak, Ioanna (2013) Review of visualisation methods for therepresentation of benefit-risk assessment ofmedication: stage 2 of 2. . PROTECT Consortium, London.

Mt-Isa, Shahrul, Peters, Ruth, Phillips, Lawrence D., Chan, Kakit, Hockley, Kimberley S., Wang, Nan, Ashby, Deborah and Tzoulak, Ioanna (2013) Review of visualisation methods for therepresentation of benefit-risk assessment ofmedication: Stage 1 of 2. . PROTECT Consortium, London.

Permanand, Govin and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2004) Theorising the development of the European Union framework for pharmaceutical regulation. . LSE Health and Social Care, London, U.K..

Phillips, Lawrence D., Amzal, Billy, Asiimwe, Alex, Chan, Edmond, Chen, Chen, Hughes, Diana, Juhaeri, Juhaeri, Micaleff, Alain, Mt-Isa, Shahrul, Noel, Becky, Shepherd, Susan and Wang, Nan (2013) IMI work package 5: report 2:b:ii benefit - riskwave 2 case study report: Rosiglitazone. . PROTECT Consortium, London.

Thambisetty, Sivaramjani (2018) Improving access to patented medicines: are human rights getting in the way? LSE Law, Society and Economy Working Papers (3/2018). Department of Law, London School of Economics and Political Science, London, UK.

Thambisetty, Sivaramjani (2013) Novartis v Union of India and the person skilled in the art: a missed opportunity. . London School of Economics and Political Science ; Social Sciences Research Network, London, UK.

Varol, Nebibe, Costa-i-Font, Joan ORCID: 0000-0001-7174-7919 and McGuire, Alistair ORCID: 0000-0002-5367-9841 (2010) Do international launch strategies of pharmaceutical corporations respond to changes in the regulatory environment? LSE Health working papers (19/2010). LSE Health, London School of Economics and Political Science, London, UK. ISBN 9780853284604

Conference or Workshop Item

Community Pharmacy Medicines Management Evaluation Team (2004) Community pharmacists’ attitudes and knowledge of medicines management. In: British Pharmaceutical Conference, 2004-09-27 - 2004-09-29, Manchester, United Kingdom, GBR. (Submitted)

Community Pharmacy Medicines Management Project Evaluation Team (2005) Community pharmacists’ perceptions and experiences of interprofessional collaboration with general practitioners. In: Health Services Research and Pharmacy Practice Conference, 2005-01-01, Reading, United Kingdom, GBR. (Submitted)

Community Pharmacy Medicines Management Project Evaluation Team (2005) Evaluating patient feedback on a new medicines management service provided by community pharmacists. In: Health Services Research and Pharmacy Practice Conference, 2005-01-01, Reading, United Kingdom, GBR. (Submitted)

Community Pharmacy Medicines Management Evaluation Team (2004) Evaluation of the Community Pharmacy Medicines Management Project. In: British Pharmaceutical Conference, 2004-09-27 - 2004-09-29, Manchester, United Kingdom, GBR. (Submitted)

Community Pharmacy Medicines Management Evaluation Team (2005) General Practitioners’ opinions of and attitudes towards a community pharmacist-led medicines management service for patients with coronary heart disease. In: Society for Academic Primary Care AGM, 2005-01-01, Newcastle, United Kingdom, GBR. (Submitted)

Community Pharmacy Medicines Management Project Evaluation Team (2005) General Practitioners’ perceptions of interprofessional collaboration with community pharmacists. In: Health Services Research and Pharmacy Practice Conference, 2005-01-01, Reading, United Kingdom, GBR. (Submitted)

Community Pharmacy Medicines Management Evaluation Team (2005) Practice staff’s views on a community pharmacy-led medicines management service. In: Health Services Research and Pharmacy Practice Conference, 2005-01-01, Reading, United Kingdom, GBR. (Submitted)

Community Pharmacy Medicines Management Evaluation Team (2005) What patients want from a pharmacy-led medicines management service. In: Health Services Research and Pharmacy Practice Conference, 2005-01-01, Reading, United Kingdom, GBR. (Submitted)

Cordella, Antonio ORCID: 0000-0002-4468-7807 (2002) Knowledge production vs knowledge management: the case of pharmaceutical R&D. In: EURAM 2nd Annual Conference: Innovative Research in Management, 2002-05-09 - 2002-05-11, Stockholm, Sweden, SWE. (Submitted)

Cordella, Antonio ORCID: 0000-0002-4468-7807 and Grisot, M. (2002) Distributed knowledge across boundaries. In: EURAM 2nd Annual Conference: Innovative Research in Management, 2002-05-09 - 2002-05-11, Stockholm, Sweden, SWE. (Submitted)

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2014) Competition issues in the distribution of pharmaceuticals. In: OECD Global Forum on Competition, 2014-02-27 - 2014-02-28, Paris, France, FRA.

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2014) Concurrence dans la distribution de produits pharmaceutiques. In: OECD Forum Mondial sur la Concurrence, 2014-02-27 - 2014-02-28, Paris, France, FRA.

Matheson, Catriona, Bond, C. and Tinelli, Michela ORCID: 0000-0002-8816-4389 (2006) Community pharmacists and drug misusers: national trends in attitudes and current practice. In: British Pharmaceutical Conference, 2006-09-04 - 2006-09-06, Manchester, United Kingdom, GBR. (Submitted)

Tinelli, Michela ORCID: 0000-0002-8816-4389, Manfrin, Andrea, Knapp, Martin ORCID: 0000-0003-1427-0215 and Mandelli, A. (2017) VP164: Applying HTA to pharmacy: the Italian-Medicine-Use-Review-HTA. In: HTAi 2017 Annual Meeting, 2017-06-17 - 2017-06-21, Rome, Italy, ITA. (Submitted)

Book

Shadlen, Kenneth C., Guennif, Samira, Guzmán, Alenka and Lalitha, N., eds. (2011) Intellectual property, pharmaceuticals and public health: access to drugs in developing countries. Edward Elgar. ISBN 9781849800143

Online resource

Angelis, Aris ORCID: 0000-0002-0261-4634 (2016) Why are the prices of new medicines so high and what can we do about it? (F8). European Health Forum Gastein (30 Sep 2016). Website.

Beckett, Charlie (2007) MMR, the media and risk. POLIS: journalism and society at the LSE (18 Jul 2007). Website.

Cohen, Lucía (2013) Pharma online: does regulation or corporate social media policy need to change to allow a real dialogue about medicines? POLIS: journalism and society at the LSE (06 Feb 2013). Website.

Cornford, Tony ORCID: 0000-0001-9202-1498 (2017) The digital future beyond the pill. Delivering Digital Drugs (10 May 2017). Website.

Costa-Font, Joan ORCID: 0000-0001-7174-7919, Rudisill, Caroline and Stefanie, Tan (2014) How important is patient brand loyalty in the uptake of generic drugs? LSE Health and Social Care (20 Mar 2014). Website.

Costa-i-Font, Joan ORCID: 0000-0001-7174-7919 (2015) Parallel trade in medicinal drugs is putting the welfare of EU patients at risk. LSE European Politics and Policy (EUROPP) Blog (20 Mar 2015). Website.

Coulter, Steve (2014) The war over drugs: what’s at stake? LSE New European Trade Unions (03 Jun 2014). Website.

Dickson, Jane (2016) $1 million for a drug used once. Delivering Digital Drugs (10 May 2016). Website.

Dickson, Jane (2015) 165,000 and counting! Delivering Digital Drugs (16 Oct 2015). Website.

Dickson, Jane (2015) Books about the future of medicine, digital doctors, patient safety etc. Delivering Digital Drugs (15 Apr 2015). Website.

Dickson, Jane (2015) D3 Research presents a poster at the LSE Research Festival. Delivering Digital Drugs (29 May 2015). Website.

Dickson, Jane (2014) The D3 project. Delivering Digital Drugs (07 Apr 2014). Website.

Dickson, Jane (2015) Digital necklace wins Unicef award. Delivering Digital Drugs (16 Dec 2015). Website.

Dickson, Jane (2015) E-prescribing and ADE in primary care – data and evidence from meaningful use in the US. Delivering Digital Drugs (14 Sep 2015). Website.

Dickson, Jane (2015) Enduring and emerging challenges of informed consent. Delivering Digital Drugs (13 Mar 2015). Website.

Dickson, Jane (2015) Mental health monitoring through ‘selfie’ videos and social media tracking. Delivering Digital Drugs (02 Feb 2015). Website.

Dickson, Jane (2015) NHS England initiative: ‘combinatorial innovation’ in NHS test beds. Delivering Digital Drugs (27 Mar 2015). Website.

Dickson, Jane (2015) National systems of patient unique identifiers – nations pro and against. Delivering Digital Drugs (10 Apr 2015). Website.

Dickson, Jane (2015) Non-adherence to prescriptions is categorical construct. Non-persistence adds a time dimension to it. Delivering Digital Drugs (14 Sep 2015). Website.

Dickson, Jane (2015) Personalized medicine: a podcast. Delivering Digital Drugs (13 Mar 2015). Website.

Dickson, Jane (2014) Pharmacogenetics test lab embedded in ePrescribing, for personalised medicine? Delivering Digital Drugs (09 Apr 2014). Website.

Dickson, Jane (2015) Precision medicine on BBC Radio 4 Today Programme. Delivering Digital Drugs (30 Oct 2015). Website.

Dickson, Jane (2014) Research hypothesis and objectives. Delivering Digital Drugs (07 Apr 2014). Website.

Dickson, Jane (2015) Results of latest international action on counterfeit and unlicensed medicines. Delivering Digital Drugs (19 Jun 2015). Website.

Dickson, Jane (2015) Serialisation of individual pills to defeat counterfeiters. Delivering Digital Drugs (10 Sep 2015). Website.

Dickson, Jane (2016) Shining a light on Lumosity’s claims. Delivering Digital Drugs (06 Jan 2016). Website.

Dickson, Jane (2015) Sounds like a diagnosis? Delivering Digital Drugs (28 Jul 2015). Website.

Dickson, Jane (2015) Stratified medicine in 2015 – Leeds Christmas lecture. Delivering Digital Drugs (19 Dec 2015). Website.

Dickson, Jane (2015) Tackling the problem of sub-standard therapeutic drugs in Kenya. Delivering Digital Drugs (19 Jun 2015). Website.

Dickson, Jane (2016) Testing & mental health apps. Delivering Digital Drugs (25 May 2016). Website.

Dickson, Jane (2015) Type 1 diabetes breakthrough. Delivering Digital Drugs (10 Sep 2015). Website.

Dickson, Jane (2016) Vita brevis ars longa: feeding Watson on dubious data. Delivering Digital Drugs (08 Mar 2016). Website.

Dickson, Jane (2017) Vocal biomarkers: diagnostics through human voice. Delivering Digital Drugs (17 Feb 2017). Website.

Dickson, Jane (2017) Warfarin history timeline. Delivering Digital Drugs (15 May 2017). Website.

Dickson, Jane (2015) Worrying about data. Delivering Digital Drugs (14 Aug 2015). Website.

Dickson, Jane (2015) A decision support tool for warfarin prescribing. Delivering Digital Drugs (13 Feb 2015). Website.

Duffin, Tony (2018) How academics and service providers are working together to inform drug policy in Ireland. LSE European Politics and Policy (EUROPP) Blog (31 Jan 2018). Website.

Dyke, Heather (2016) Why is doping wrong anyway? LSE Philosophy Blog (17 Aug 2016). Website.

Evans-Lacko, Sara ORCID: 0000-0003-4691-2630 and Knapp, Martin ORCID: 0000-0003-1427-0215 (2016) Cost of depression in the workplace across eight diverse countries – collectively US$250 billion. LSE Health and Social Care (15 Nov 2016). Website.

Ford, Alessandro (2020) Book review: Enforcing Freedom: Drug Courts, Therapeutic Communities and the Intimacies of the State by Kerwin Kaye. USApp – American Politics and Policy Blog (07 Jun 2020). Blog Entry.

Ford, Alessandro (2020) Book review: Pills, powder and smoke: inside the bloody war on drugs by Antony Loewenstein. USApp – American Politics and Policy Blog (06 Jul 2020). Blog Entry.

Hannah, A. Lee and Mallinson, Daniel J. (2020) How the US states have learned from each other to create more comprehensive medical cannabis policies. USApp – American Politics and Policy Blog (17 Jul 2020). Blog Entry.

Hibberd, Ralph (2016) Accelerating access to new drugs in Japan. Delivering Digital Drugs (11 May 2016). Website.

Hibberd, Ralph (2017) Brexit and the falsified medicines directive. Delivering Digital Drugs (17 Feb 2017). Website.

Hibberd, Ralph (2016) Combating falsified medicines in Africa through digital artefacts. Delivering Digital Drugs (27 Sep 2016). Website.

Hibberd, Ralph (2016) Hub and spoke dispensing: privacy and sociotechnical rigidity. Delivering Digital Drugs (08 Jul 2016). Website.

Hibberd, Ralph (2016) Hub and spoke dispensing: safety and sociotechnical pliability. Delivering Digital Drugs (07 Jul 2016). Website.

Lichtner, Valentina (2016) ‘the little liar’ – patient information about medicines. Delivering Digital Drugs (10 May 2016). Website.

Morais de Oliveira, Iago (2016) Using international human rights law to guarantee the right to health: a Brazilian experience. LSE Human Rights Blog (13 Dec 2016). Website.

Mossialos, Elias ORCID: 0000-0001-8664-9297, Ge, Yanfeng, Hu, Jia and Wang, Liejun (2016) Building a strong pharmaceutical system for China. LSE Health and Social Care (07 Jul 2016). Website.

Olczak, Kaya, Salcher, Maximillian and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2016) What works best in congenital heart disease? Comparing two interventions for treatment of Aortic Coarctation. LSE Health and Social Care (02 Sep 2016). Website.

Pettus, Katherine (2020) The Covid-19 pandemic means that the running down of US Strategic Stockpile of medicines could not have come at a worse time. USApp-American Politics and Policy Blog (11 Apr 2020). Blog Entry.

Relle, Katherine (2013) Why social media is good for medicine and why pharmaceutical companies should engage online. POLIS: journalism and society at the LSE (28 Jan 2013). Website.

Renewick, Matthew, Simpkin, Victoria and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2016) Targeting innovation in antibiotics. LSE Health and Social Care (01 Jul 2016). Website.

Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2016) Debating Patents and Drug Prices: Trade Agreements and the Trans-Pacific Partnership. International Development (02 Nov 2016). Website.

Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2013) Learning from India? A new approach to secondary pharmaceutical patents. (03 May 2013). Website.

Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 and Sampat, Bhaven N. (2015) Drug patenting in India: looking back and looking forward. South Asia @ LSE (09 Nov 2015). Blog Entry.

Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835, Sampat, Bhaven N. and Amin, Tahir M. (2012) Balancing innovation and access: India’s pharmaceutical patent laws. (23 Jul 2012). Website.

Shaked, Yoav (2021) Big Pharma must embrace the shift to technological solutions in healthcare. LSE Business Review (16 Dec 2021). Blog Entry.

Thambisetty, Sivaramjani (2013) Compulsory licenses for pharmaceuticals: an inconvenient truth? India at LSE (25 Mar 2013). Website.

Vazza, Lucilla (2016) In Italy primary care prescriptions all electronic from 1 March 2016. Delivering Digital Drugs (28 Feb 2016). Website.

Williams, Thomas Christie (2017) Long read review: drug dealer, MD: how doctors were duped, patients got hooked and why it’s so hard to stop by Anna Lembke. LSE Review of Books (22 Mar 2017). Website.

Thesis

Tinelli, Michela ORCID: 0000-0002-8816-4389 (2007) Developing and applying discrete choice experiments (DCEs) to inform pharmacy policy. Doctoral thesis, University of Aberdeen.